Kumar, K;
Abubakar, I;
(2015)
Clinical implications of the global multidrug-resistant tuberculosis epidemic.
Clinical Medicine
, 15
(Sup 6)
s37-s42.
10.7861/clinmedicine.15-6-s37.
Preview |
Text
Abubakar_clinical implications of the global_s37-s42 vor.pdf - Published Version Download (211kB) | Preview |
Abstract
Multidrug-resistant tuberculosis (MDR TB) is a significant threat to global health estimated to account for nearly half a million new cases and over 200,000 deaths in 2013. The number of MDR TB cases in the UK has risen over the last 15 years, with ever more complex clinical cases and associated challenging public health and societal implications. In this review, we provide an overview of the epidemiology of MDR TB globally and in the UK, outline the clinical management of MDR TB and summarise recent advances in diagnostics and prospects for new treatment.
| Type: | Article |
|---|---|
| Title: | Clinical implications of the global multidrug-resistant tuberculosis epidemic |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.7861/clinmedicine.15-6-s37 |
| Publisher version: | http://doi.org/10.7861/clinmedicine.15-6-s37 |
| Language: | English |
| Additional information: | Copyright © Royal College of Physicians 2017. All rights reserved. |
| Keywords: | Multidrug-resistant tuberculosis, epidemiology, diagnostics, treatment |
| UCL classification: | UCL |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1483310 |
Archive Staff Only
 |
View Item |
